Graham Capital Management, L.P. Veracyte, Inc. Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Veracyte, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,686 shares of VCYT stock, worth $636,696. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,686
Previous 28,363
37.64%
Holding current value
$636,696
Previous $840,000
43.1%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding VCYT
# of Institutions
295Shares Held
77.2MCall Options Held
0Put Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA8.1MShares$292 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$281 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$189 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$137 Million0.85% of portfolio
-
Wellington Management Group LLP Boston, MA3.47MShares$125 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.58B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...